文献速递心力衰竭与心肌病

中心体结构重组障碍是人类婴儿扩张型心肌病的基础

Impaired Reorganization of Centrosome Structure Underlies Human Infantile Dilated Cardiomyopathy.
PubMed 文献 · Circulation · 2023-03-27

研究从一例左室射血分数18%的婴儿扩张型心肌病(iDCM)患者出发,通过全外显子测序和CRISPR/Cas9敲除/校正鉴定RTTN为致病基因,首次将中心体缺陷与非综合征性扩张型心肌病关联;患者来源iPSC模型显示中心体持续定位于中心粒而非预期的核周重组,导致微管网络缺陷和心肌细胞成熟障碍,小分子可恢复中心体重组并改善结构与收缩力。

要点

  • RTTN是首个被鉴定与非综合征性婴儿扩张型心肌病相关的中心体基因。
  • iDCM心肌细胞中心体未发生核周重组,导致全局微管网络缺陷。
  • 小分子恢复中心体重组可改善iDCM心肌细胞结构与收缩力。

核心结论

  • 本研究首次证明中心体还原缺陷可导致人类疾病,即婴儿扩张型心肌病。
  • RTTN在围产期心脏发育中具有新作用,中心体相关iDCM存在潜在治疗策略。

研究设计与样本

  • 从一例左室射血分数18%的婴儿iDCM患者出发,建立患者来源iPSC体外模型。
  • 对患者及父母行全外显子测序,并用CRISPR/Cas9敲除与校正在体外验证。
  • 采用斑马鱼和果蝇模型进行体内验证,并用Matrigel mattress技术与单细胞RNA测序表征心肌细胞。

主要发现

  • 全外显子测序与CRISPR/Cas9敲除/校正鉴定RTTN为致病基因。
  • 斑马鱼和果蝇基因敲低证实RTTN对心脏结构与功能的要求在进化上保守。
  • iDCM心肌细胞单细胞RNA测序显示成熟受损,对应结构与功能缺陷。
  • 中心体持续定位于中心粒,而非预期的核周重组,导致全局微管网络缺陷。
  • 一种小分子可恢复中心体重组并改善iDCM心肌细胞结构与收缩力。

关键数值与推荐

  • 患者左室射血分数为18%,伴肌节和线粒体结构破坏。
  • RTTN被鉴定为致病基因,为首次将中心体缺陷与非综合征性扩张型心肌病关联。

临床怎么用

  • 对婴儿扩张型心肌病可考虑中心体相关基因RTTN的遗传学评估。
  • 中心体重组是iDCM的潜在治疗靶点,小分子干预在体外模型中显示改善作用。

局限性

  • 研究基于单例患者,结论外推需更多病例验证。
  • 小分子治疗效果仅在体外iPSC来源心肌细胞中观察。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: During cardiomyocyte maturation, the centrosome, which functions as a microtubule organizing center in cardiomyocytes, undergoes dramatic structural reorganization where its components reorganize from being localized at the centriole to the nuclear envelope. This developmentally programmed process, referred to as centrosome reduction, has been previously associated with cell cycle exit. However, understanding of how this process influences cardiomyocyte cell biology, and whether its disruption results in human cardiac disease, remains unknown. We studied this phenomenon in an infant with a rare case of infantile dilated cardiomyopathy (iDCM) who presented with left ventricular ejection fraction of 18% and disrupted sarcomere and mitochondria structure. METHODS: We performed an analysis beginning with an infant who presented with a rare case of iDCM. We derived induced pluripotent stem cells from the patient to model iDCM in vitro. We performed whole exome sequencing on the patient and his parents for causal gene analysis. CRISPR/Cas9-mediated gene knockout and correction in vitro were used to confirm whole exome sequencing results. Zebrafish and Drosophila models were used for in vivo validation of the causal gene. Matrigel mattress technology and single-cell RNA sequencing were used to characterize iDCM cardiomyocytes further. RESULTS: Whole exome sequencing and CRISPR/Cas9 gene knockout/correction identified RTTN, the gene encoding the centrosomal protein RTTN (rotatin), as the causal gene underlying the patient's condition, representing the first time a centrosome defect has been implicated in a nonsyndromic dilated cardiomyopathy. Genetic knockdowns in zebrafish and Drosophila confirmed an evolutionarily conserved requirement of RTTN for cardiac structure and function. Single-cell RNA sequencing of iDCM cardiomyocytes showed impaired maturation of iDCM cardiomyocytes, which underlie the observed cardiomyocyte structural and functional deficits. We also observed persistent localization of the centrosome at the centriole, contrasting with expected programmed perinuclear reorganization, which led to subsequent global microtubule network defects. In addition, we identified a small molecule that restored centrosome reorganization and improved the structure and contractility of iDCM cardiomyocytes. CONCLUSIONS: This study is the first to demonstrate a case of human disease caused by a defect in centrosome reduction. We also uncovered a novel role for RTTN in perinatal cardiac development and identified a potential therapeutic strategy for centrosome-related iDCM. Future study aimed at identifying variants in centrosome components may uncover additional contributors to human cardiac disease.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Chun YW, Miyamoto M, Williams CH, et al. Impaired Reorganization of Centrosome Structure Underlies Human Infantile Dilated Cardiomyopathy. Circulation. 2023. PMID: 36970983. doi:10.1161/CIRCULATIONAHA.122.060985

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。